Climate change and allergic diseases

Annals of Allergy, Asthma & Immunology

September 2012 Volume 109, Issue 3, Pages 166-172 CME Review


Overall Purpose
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for ContinuingMedical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee
Gina Dapul-Hidalgo, MD (Sr Author)
Leonard Bielory, MD, MS (Author)
Mitchell H. Grayson, MD (Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:
● Describe the potential effects of climate change on allergic diseases, including allergic 
   rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma.
● Recognize the impact of climate change on allergic diseases and the related 
   need to minimize gas emissions through various global and regional mitigation efforts.
  

Additional information
Disclosure: 

G. Dapul-Hidalgo, MD has nothing to disclose. L. Bielory, MD, MS has received grant/research support from the United States Environmental Protection Agency (US EPA) and is a consultant for ISTA and Allergan.M.H. Grayson has received grant/research support from the National Institutes of Health (NIH) andChildren’sResearch Institute/MedicalCollege ofWisconsin.G.D.Marshallhas received grant/research support from theHealthResources and Services Administration (HRSA) and the National Institutes of Health (NIH). No unapproved/investigative use of a product/device is discussed.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
09/01/2012
Course expires: 
08/31/2014
Cost:
$0.00
Rating: 
0

Gina Dapul-Hidalgo, MD and Leonard Bielory, MD, MS 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
09/01/2012
Course expires: 
08/31/2014

Price

Cost:
$0.00
Please login or create an account to take this course.